Biovica International AB Cash Flow Statement

Financials in millions SEK. Fiscal year is May - April.

Millions SEK. Fiscal year is May - Apr.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Apr '26 Apr 30, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022
Net Income	-70.12	-85.84	-126.85	-110.46	-60.1
Depreciation & Amortization	8.3	8.84	9.43	8.21	6.44
Other Adjustments	1.8	-0.12	0.12	-0.09	-0.18
Change in Receivables	-3.45	-0.22	-0.4	-0.72	-1.73
Changes in Inventories	-0.43	-0.09	-0.59	0.1	-1.01
Changes in Other Operating Activities	1.09	-7.95	3.71	8.31	4.46
Operating Cash Flow	-62.81	-85.37	-114.58	-94.64	-52.13
Capital Expenditures	-0.47	-0.29	-0.15	-1.21	-0.41
Purchases of Intangible Assets	-	-	-	-1.57	-2.99
Purchases of Investments	-	-	-0.44	-	-
Investing Cash Flow	-0.47	-0.29	-0.59	-2.78	-3.4
Long-Term Debt Issued	10	-	-	-	-
Long-Term Debt Repaid	-13	-3.31	-2.97	-2.9	-1.34
Net Long-Term Debt Issued (Repaid)	-3	-3.31	-2.97	-2.9	-1.34
Issuance of Common Stock	122.3	35.84	99.12	150.09	1.2
Net Common Stock Issued (Repurchased)	122.3	35.84	99.12	150.09	1.2
Other Financing Activities	-9.95	-1.6	-16.65	-25.18	-
Financing Cash Flow	109.36	30.93	79.5	122.01	-0.14
Effect of Exchange Rate Changes on Cash and Cash Equivalents	-0.08	-0.26	0.74	-0.05	0.09
Net Cash Flow	46.08	-54.73	-35.66	24.59	-55.66
Free Cash Flow	-63.28	-85.65	-114.72	-95.85	-52.53
FCF Margin	-419.13%	-781.51%	-1381.68%	-1682.99%	-834.37%
Free Cash Flow Per Share	-0.27	-0.93	-1.96	-2.75	-1.85
Levered Free Cash Flow	-64.38	-90.42	-115.39	-97.98	-51.86
Unlevered Free Cash Flow	-61.28	-83.68	-113.74	-95.23	-50.6